Related Experiment Video
Updated: May 7, 2026

Noninvasive Assessment of Cardiac Abnormalities in Experimental Autoimmune Myocarditis by Magnetic Resonance Microscopy Imaging in the Mouse
Published on: June 20, 2014
Immune myocarditis induced by sintilimab therapy: A case report
Yu Li1,2, Baowei Zhai2, Ben Yang1
1Translational Medical Center, Weifang Second People's Hospital, Weifang Respiratory Disease Hospital, Weifang, Shandong 261041, P.R. China.
Immune checkpoint inhibitors (ICIs) can cause myocarditis, a rare but serious heart inflammation. Early diagnosis and hormonal shock therapy led to a breast cancer patient's recovery, highlighting the need for vigilance.
Area of Science:
- Cardiology
- Oncology
- Immunology
Background:
- Immune checkpoint inhibitors (ICIs) are crucial cancer therapies.
- Immune-related adverse events (irAEs), including myocarditis, are significant concerns.
- Myocarditis can lead to severe cardiac dysfunction and arrhythmias.
More Related Videos
14:24Percutaneous Contrast Echocardiography-guided Intramyocardial Injection and Cell Delivery in a Large Preclinical Model
Published on: January 21, 2018
08:03Ultrasound-Guided Induced Pluripotent Stem Cell-Derived Cardiomyocyte Implantation in Myocardial Infarcted Mice
Published on: March 30, 2022
Related Concept Videos
Myocarditis I: Introduction
Myocarditis II: Clinical Features and Diagnostic Tests
Myocarditis III: Medical Management
Myocarditis IV: Nursing Management
Pericarditis I: Introduction
Pericarditis III: Medical Management